Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
AstraZeneca PLC (AZN) had Debt to Capital Ratio of 0.36 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$14.46B |
|
$2.45B |
|
$2.47B |
|
$11.98B |
|
$10.95B |
|
$3.51B |
|
$-381.00M |
|
$3.13B |
|
$3.13B |
|
$2.45B |
|
$2.45B |
|
$2.45B |
|
$2.45B |
|
$3.51B |
|
$4.90B |
|
3.10B |
|
3.12B |
|
$0.79 |
|
$0.79 |
|
| Balance Sheet Financials | |
$28.94B |
|
$11.64B |
|
$83.48B |
|
$112.42B |
|
$33.54B |
|
$24.71B |
|
$34.08B |
|
$67.61B |
|
$44.81B |
|
$-14.34B |
|
$44.81B |
|
-- |
|
| Cash Flow Statement Financials | |
$7.10B |
|
$-3.36B |
|
$-2.19B |
|
$5.43B |
|
$7.03B |
|
$1.60B |
|
-- |
|
$-3.36B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.86 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.36 |
0.70 |
|
82.89% |
|
24.27% |
|
24.27% |
|
-- |
|
21.63% |
|
16.95% |
|
$6.02B |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.38 |
|
0.95 |
|
94.43 |
|
5.46% |
|
-17.07% |
|
2.18% |
|
3.52% |
|
-- |
|
$1.93 |
|
$2.28 |
|